Product Information
AMLODIPINE-ATORVAST 10-80 MG is a generic product labeled by Apotex Corp., priced at $1.5651 per EA under NDC 60505349303. Its NADAC has been published 290 times since Sep 16, 2020.
FDA first approved this application on Nov 18, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10; 80 mg/1; mg/1
Manufacturer
Apotex Corp.NDC
60505349303
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA205199FDA Approved
11/18/2019
TE Code
AB
On Market Since
7/29/2020
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-ATORVAST 10-80 MG has been published 290 times since Sep 16, 2020, and over the history we have for it it has declined 52.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5651 per EA |
|---|---|
| All-time high | $4.0268 (Feb 15, 2023) |
| All-time low | $1.5651 (Sep 23, 2026) |
| 52-week high | $2.1966 |
| 52-week low | $1.5651 |
| Median price | $3.2441 |
| Average price | $2.8353 |
| Largest weekly change | -30.3% (Apr 17, 2024) |
| Weeks tracked | 290 |
| Tracking since | Sep 16, 2020 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amlodipine and Atorvastatin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMLODIPINE-ATORVAST 10-80 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-ATORVAST 10-80 MG, manufactured by Apotex Corp., is $1.5651 per EA (NDC 60505349303), effective Sep 30, 2026.
How has the price of AMLODIPINE-ATORVAST 10-80 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-ATORVAST 10-80 MG has declined 52.6%. It has been tracked across 290 weekly CMS publications since Sep 16, 2020.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-ATORVAST 10-80 MG?
Since Sep 16, 2020, the NADAC for AMLODIPINE-ATORVAST 10-80 MG has ranged from a low of $1.5651 (Sep 23, 2026) to a high of $4.0268 (Feb 15, 2023), with a median of $3.2441 per EA.
Are there cheaper alternatives to AMLODIPINE-ATORVAST 10-80 MG?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-ATORVAST 10-80 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures AMLODIPINE-ATORVAST 10-80 MG?
AMLODIPINE-ATORVAST 10-80 MG (NDC 60505349303) is labeled by Apotex Corp., and CMS classifies it as a generic product.